{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:28Z","timestamp":1794047488071,"version":"4.8.0"},"reference-count":30,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"7","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Plasma metabolomics analysis was performed on 44 patients with relapsed\/refractory B-cell non-Hodgkin lymphoma (r\/r\/BNHL) infused with approved CD19 chimeric antigen receptor (CAR) T-cell products at the time of pre-lymphodepletion (PLD) and at day +1 (D1), D7, and D30 after CAR T-cell infusion. At the PLD time point, a metabolic profile characterized by high lipoproteins and lactate and low glucose contributed to poor outcome prediction in association with high lactate dehydrogenase levels. At D1, higher plasma levels of lipid metabolism products and lower glucose and glycoproteins levels were observed in tisa-cel-compared to axi-cel-treated patients. At D30, discriminant analysis found two clusters in a subgroup of patients, one with complete response lasting 1 year after therapy, and another who relapsed within 1 year (relapsed &gt;D30). This latter showed a higher content of N-GlycA, a known biomarker of systemic inflammation that is also correlated with C-reactive protein in our case setting of relapsing patients. Our data show complex metabolomic changes that track the evolution of the disease and drug activity in the first 30 days of CAR T-cell therapy. Conceivably, a pro-inflammatory drift may be linked to a forthcoming disease relapse in CAR T patients.<\/jats:p>","DOI":"10.3324\/haematol.2024.285154","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T02:56:53Z","timestamp":1734577013000},"page":"1545-1554","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic profile evolution in relapsed\/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome"],"prefix":"10.3324","volume":"110","author":[{"given":"Serena","family":"De Matteis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Del Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Giudetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Iannotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Tomassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Naddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Storci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Laprovitera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Messelodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Nicola","family":"Bertuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sinigaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Maffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pirazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Garagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Fanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bonaf\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"76501","doi-asserted-by":"crossref","unstructured":"Crump M, Neelapu SS, Farooq U. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017; 130(16):1800-1808.","DOI":"10.1182\/blood-2017-03-769620"},{"key":"76502","doi-asserted-by":"crossref","unstructured":"Locke FL, Rossi JM, Neelapu SS. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020; 4(19):4898-4911.","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"76503","doi-asserted-by":"crossref","unstructured":"Nastoupil LJ, Jain MD, Feng L. Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium. J Clin Oncol. 2020; 38(27):3119-3128.","DOI":"10.1200\/JCO.19.02104"},{"key":"76504","doi-asserted-by":"crossref","unstructured":"Lee DW, Santomasso BD, Locke FL. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019; 25(4):625-638.","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"76505","doi-asserted-by":"crossref","unstructured":"Sud M, Fahy E, Cotter D. Metabolomics Workbench: an international repository for metabolomics data and Metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 2016; 44(D1):D463-470.","DOI":"10.1093\/nar\/gkv1042"},{"key":"76506","doi-asserted-by":"crossref","unstructured":"Girelli CR, Del Coco L, Papadia P, De Pascali SA, Fanizzi FP. Harvest year effects on Apulian EVOOs evaluated by 1H NMR based metabolomics. PeerJ. 2016; 4:e2740.","DOI":"10.7717\/peerj.2740"},{"key":"76507","doi-asserted-by":"crossref","unstructured":"Del Coco L, Felline S, Girelli CR. 1H NMR Spectroscopy and MVA to evaluate the effects of caulerpin-based diet on Diplodus sargus lipid profiles. Mar Drugs. 2018; 16(10):390.","DOI":"10.3390\/md16100390"},{"key":"76508","doi-asserted-by":"crossref","unstructured":"Chong J, Soufan O, Li C. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucl Acids Res. 2018; 46(W1):W486-W494.","DOI":"10.1093\/nar\/gky310"},{"key":"76509","doi-asserted-by":"crossref","unstructured":"Vanhooren V, Laroy W, Libert C, Chen C. N-glycans profiling in the study of human aging. Biogerontology. 2008; 9(5):351-356.","DOI":"10.1007\/s10522-008-9140-z"},{"key":"76510","doi-asserted-by":"crossref","unstructured":"Vanhooren V, Dewaele S, Libert C. Serum N-glycan profile shift during human ageing. Exp. Gerontol. 2010; 45(10):738-743.","DOI":"10.1016\/j.exger.2010.08.009"},{"key":"76511","doi-asserted-by":"crossref","unstructured":"Westin JR, Tam CS, Borchmann P. Correlative analyses of patient and clinical characteristics associated with efficacy in tisagenlecleucel-treated relapsed\/refractory diffuse large B-cell lymphoma patients in the Juliet trial. Blood. 2019; 134(Suppl 1):4103.","DOI":"10.1182\/blood-2019-129107"},{"key":"76512","doi-asserted-by":"crossref","unstructured":"Detroit M, Collier M, Beeker N. Predictive factors of response to immunotherapy in lymphomas: a multicentre clinical data warehouse study (PRONOSTIM). Cancers (Basel). 2023; 15(16):4028.","DOI":"10.3390\/cancers15164028"},{"key":"76513","doi-asserted-by":"crossref","unstructured":"Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL receptor LOX- 1 in atherogenesis and tumorigenesis. Antioxid Redox Signal. 2011; 15(8):2301-2333.","DOI":"10.1089\/ars.2010.3792"},{"key":"76514","doi-asserted-by":"crossref","unstructured":"Khojandi N, Kuehm LM, Piening A. Oxidized lipoproteins promote resistance to cancer immunotherapy independent of patient obesity. Cancer Immunol Res. 2021; 9(2):214-226.","DOI":"10.1158\/2326-6066.CIR-20-0358"},{"key":"76515","doi-asserted-by":"crossref","unstructured":"Kawalekar OU, O\u2019Connor RS, Fraietta JA. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity. 2016; 44(3):712.","DOI":"10.1016\/j.immuni.2016.02.023"},{"key":"76516","doi-asserted-by":"crossref","unstructured":"Frauwirth KA, Riley JL, Harris MH. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002; 16(6):769-777.","DOI":"10.1016\/S1074-7613(02)00323-0"},{"key":"76517","doi-asserted-by":"crossref","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020; 33:48-66.","DOI":"10.1016\/j.molmet.2019.07.006"},{"key":"76518","doi-asserted-by":"crossref","unstructured":"Chen P, Zuo H, Xiong H. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci U S A. 2017; 114(3):580-585.","DOI":"10.1073\/pnas.1614035114"},{"key":"76519","doi-asserted-by":"crossref","unstructured":"Colegio OR, Chu NQ, Szabo AL. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014; 513(7519):559-563.","DOI":"10.1038\/nature13490"},{"key":"76520","doi-asserted-by":"crossref","unstructured":"Husain Z, Huang Y, Seth P, Sukhatme VP. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol. 2013; 191(3):1486-1495.","DOI":"10.4049\/jimmunol.1202702"},{"key":"76521","doi-asserted-by":"crossref","unstructured":"Fischer K, Hoffmann P, Voelkl S. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-3819.","DOI":"10.1182\/blood-2006-07-035972"},{"key":"76522","doi-asserted-by":"crossref","unstructured":"Uhl FM, Chen S, O\u2019Sullivan D. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans. Sci Transl Med. 2020; 12(567):eabb8969.","DOI":"10.1126\/scitranslmed.abb8969"},{"key":"76523","doi-asserted-by":"crossref","unstructured":"Yang L, Chu Z, Liu M. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J Hematol Oncol. 2023; 16(1):59.","DOI":"10.1186\/s13045-023-01453-1"},{"key":"76524","doi-asserted-by":"crossref","unstructured":"Igel P, Dove S, Buschauer A. Histamine H4 receptor agonists. Bioorg Med Chem Lett. 2010; 20(24):7191-7199.","DOI":"10.1016\/j.bmcl.2010.10.041"},{"key":"76525","doi-asserted-by":"crossref","unstructured":"O\u2019Mahony L, Akdis M, Cezmi AA. Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol. 2011; 128(6):1153-1162.","DOI":"10.1016\/j.jaci.2011.06.051"},{"key":"76526","doi-asserted-by":"crossref","unstructured":"Noel M, Chasman DI, Mora S. The inflammation biomarker GlycA reflects plasma N-Glycan branching. Clin Chem. 2023; 69(1):80-87.","DOI":"10.1093\/clinchem\/hvac160"},{"key":"76527","doi-asserted-by":"crossref","unstructured":"Otvos JD, Shalaurova I, Wolak-Dinsmore J. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015; 61(5):714-723.","DOI":"10.1373\/clinchem.2014.232918"},{"key":"76528","doi-asserted-by":"crossref","unstructured":"Liu Y, Jie X, Nian L. A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed\/refractory multiple myeloma patients treated with CAR-T cells. Front Immunol. 2023; 14:1169071.","DOI":"10.3389\/fimmu.2023.1169071"},{"key":"76529","doi-asserted-by":"crossref","unstructured":"Dall\u2019Olio F, Vanhooren V, Chen CC, Slagboom PE, Wuhrer M, Franceschi C. N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev. 2013; 12(2):685-698.","DOI":"10.1016\/j.arr.2012.02.002"},{"key":"76530","doi-asserted-by":"crossref","unstructured":"Saldova R, Royle L, Radcliffe CM. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 2007; 17(12):1344-1356.","DOI":"10.1093\/glycob\/cwm100"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/11875\/77917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11875\/78517","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11875\/77917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:53Z","timestamp":1794046073000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/11875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285154","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}